Sexual dysfunctions include sexual disorders of men and women that can interfere with their sexual performance, leading to unsatisfied sexual intercourse. The major drugs used in this market are PDE5 inhibitors, whereas other drugs such as hormone-related and transurethral also have a presence in the market.
This report aims to provide a comprehensive presentation of the global market for Sexual Dysfunction Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sexual Dysfunction Drugs. This report contains market size and forecasts of Sexual Dysfunction Drugs in global, including the following market information:
Global Sexual Dysfunction Drugs Market Revenue, 2019-2024, 2024-2029, ($ millions)
Global Sexual Dysfunction Drugs Market Sales, 2019-2024, 2024-2029, (K Pcs)
Global top five Sexual Dysfunction Drugs companies in 2023 (%)
The global Sexual Dysfunction Drugs market was valued at US$ million in 2023 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The sexual dysfunction oral drugs segment accounted for the majority market share during 2017 and will continue to grow during the forecast period. The increasing cases of sexual dysfunctions are driving the need for oral therapies such as 5HT1A receptor agonist. The demand for sexual dysfunction oral drugs such as ED drugs will further increase due to the rising awareness among healthcare professionals.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Sexual Dysfunction Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Sexual Dysfunction Drugs Market, by Type, 2019-2024, 2024-2029 ($ Millions) & (K Pcs)
Global Sexual Dysfunction Drugs Market Segment Percentages, by Type, 2023 (%)
Oral Therapy
Intracavernosal Therapy
Hormonal Therapy
Transurethral Therapy
Global Sexual Dysfunction Drugs Market, by User, 2019-2024, 2024-2029 ($ Millions) & (K Pcs)
Global Sexual Dysfunction Drugs Market Segment Percentages, by User, 2023 (%)
Male
Female
Global Sexual Dysfunction Drugs Market, By Region and Country, 2019-2024, 2024-2029 ($ Millions) & (K Pcs)
Global Sexual Dysfunction Drugs Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Sexual Dysfunction Drugs revenues in global market, 2019-2024 (Estimated), ($ millions)
Key companies Sexual Dysfunction Drugs revenues share in global market, 2023 (%)
Key companies Sexual Dysfunction Drugs sales in global market, 2019-2024 (Estimated), (K Pcs)
Key companies Sexual Dysfunction Drugs sales share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
GlaxoSmithKline
Merck
Eli Lilly
AbbVie
Bayer
Teva Pharmaceutical Industries
Takeda
Apricus Biosciences
Emotional Brain
Ivix LLX
Leadiant Biosciences
NexMed
S1 Biopharma
Vietstar Biomedical Research
Outline of Major Chapters:
Chapter 1: Introduces the definition of Sexual Dysfunction Drugs, market overview.
Chapter 2: Global Sexual Dysfunction Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of Sexual Dysfunction Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by user, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Sexual Dysfunction Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Sexual Dysfunction Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Sexual Dysfunction Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by User
1.3 Global Sexual Dysfunction Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Sexual Dysfunction Drugs Overall Market Size
2.1 Global Sexual Dysfunction Drugs Market Size: 2022 VS 2031
2.2 Global Sexual Dysfunction Drugs Revenue, Prospects & Forecasts: 2019-2031
2.3 Global Sexual Dysfunction Drugs Sales: 2019-2031
3 Company Landscape
3.1 Top Sexual Dysfunction Drugs Players in Global Market
3.2 Top Global Sexual Dysfunction Drugs Companies Ranked by Revenue
3.3 Global Sexual Dysfunction Drugs Revenue by Companies
3.4 Global Sexual Dysfunction Drugs Sales by Companies
3.5 Global Sexual Dysfunction Drugs Price by Manufacturer (2019-2024)
3.6 Top 3 and Top 5 Sexual Dysfunction Drugs Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Sexual Dysfunction Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Sexual Dysfunction Drugs Players in Global Market
3.8.1 List of Global Tier 1 Sexual Dysfunction Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Sexual Dysfunction Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Sexual Dysfunction Drugs Market Size Markets, 2022 & 2031
4.1.2 Oral Therapy
4.1.3 Intracavernosal Therapy
4.1.4 Hormonal Therapy
4.1.5 Transurethral Therapy
4.2 By Type - Global Sexual Dysfunction Drugs Revenue & Forecasts
4.2.1 By Type - Global Sexual Dysfunction Drugs Revenue, 2019-2024
4.2.2 By Type - Global Sexual Dysfunction Drugs Revenue, 2024-2031
4.2.3 By Type - Global Sexual Dysfunction Drugs Revenue Market Share, 2019-2031
4.3 By Type - Global Sexual Dysfunction Drugs Sales & Forecasts
4.3.1 By Type - Global Sexual Dysfunction Drugs Sales, 2019-2024
4.3.2 By Type - Global Sexual Dysfunction Drugs Sales, 2024-2031
4.3.3 By Type - Global Sexual Dysfunction Drugs Sales Market Share, 2019-2031
4.4 By Type - Global Sexual Dysfunction Drugs Price (Manufacturers Selling Prices), 2019-2031
5 Sights by User
5.1 Overview
5.1.1 By User - Global Sexual Dysfunction Drugs Market Size, 2022 & 2031
5.1.2 Male
5.1.3 Female
5.2 By User - Global Sexual Dysfunction Drugs Revenue & Forecasts
5.2.1 By User - Global Sexual Dysfunction Drugs Revenue, 2019-2024
5.2.2 By User - Global Sexual Dysfunction Drugs Revenue, 2024-2031
5.2.3 By User - Global Sexual Dysfunction Drugs Revenue Market Share, 2019-2031
5.3 By User - Global Sexual Dysfunction Drugs Sales & Forecasts
5.3.1 By User - Global Sexual Dysfunction Drugs Sales, 2019-2024
5.3.2 By User - Global Sexual Dysfunction Drugs Sales, 2024-2031
5.3.3 By User - Global Sexual Dysfunction Drugs Sales Market Share, 2019-2031
5.4 By User - Global Sexual Dysfunction Drugs Price (Manufacturers Selling Prices), 2019-2031
6 Sights by Region
6.1 By Region - Global Sexual Dysfunction Drugs Market Size, 2022 & 2031
6.2 By Region - Global Sexual Dysfunction Drugs Revenue & Forecasts
6.2.1 By Region - Global Sexual Dysfunction Drugs Revenue, 2019-2024
6.2.2 By Region - Global Sexual Dysfunction Drugs Revenue, 2024-2031
6.2.3 By Region - Global Sexual Dysfunction Drugs Revenue Market Share, 2019-2031
6.3 By Region - Global Sexual Dysfunction Drugs Sales & Forecasts
6.3.1 By Region - Global Sexual Dysfunction Drugs Sales, 2019-2024
6.3.2 By Region - Global Sexual Dysfunction Drugs Sales, 2024-2031
6.3.3 By Region - Global Sexual Dysfunction Drugs Sales Market Share, 2019-2031
6.4 North America
6.4.1 By Country - North America Sexual Dysfunction Drugs Revenue, 2019-2031
6.4.2 By Country - North America Sexual Dysfunction Drugs Sales, 2019-2031
6.4.3 US Sexual Dysfunction Drugs Market Size, 2019-2031
6.4.4 Canada Sexual Dysfunction Drugs Market Size, 2019-2031
6.4.5 Mexico Sexual Dysfunction Drugs Market Size, 2019-2031
6.5 Europe
6.5.1 By Country - Europe Sexual Dysfunction Drugs Revenue, 2019-2031
6.5.2 By Country - Europe Sexual Dysfunction Drugs Sales, 2019-2031
6.5.3 Germany Sexual Dysfunction Drugs Market Size, 2019-2031
6.5.4 France Sexual Dysfunction Drugs Market Size, 2019-2031
6.5.5 U.K. Sexual Dysfunction Drugs Market Size, 2019-2031
6.5.6 Italy Sexual Dysfunction Drugs Market Size, 2019-2031
6.5.7 Russia Sexual Dysfunction Drugs Market Size, 2019-2031
6.5.8 Nordic Countries Sexual Dysfunction Drugs Market Size, 2019-2031
6.5.9 Benelux Sexual Dysfunction Drugs Market Size, 2019-2031
6.6 Asia
6.6.1 By Region - Asia Sexual Dysfunction Drugs Revenue, 2019-2031
6.6.2 By Region - Asia Sexual Dysfunction Drugs Sales, 2019-2031
6.6.3 China Sexual Dysfunction Drugs Market Size, 2019-2031
6.6.4 Japan Sexual Dysfunction Drugs Market Size, 2019-2031
6.6.5 South Korea Sexual Dysfunction Drugs Market Size, 2019-2031
6.6.6 Southeast Asia Sexual Dysfunction Drugs Market Size, 2019-2031
6.6.7 India Sexual Dysfunction Drugs Market Size, 2019-2031
6.7 South America
6.7.1 By Country - South America Sexual Dysfunction Drugs Revenue, 2019-2031
6.7.2 By Country - South America Sexual Dysfunction Drugs Sales, 2019-2031
6.7.3 Brazil Sexual Dysfunction Drugs Market Size, 2019-2031
6.7.4 Argentina Sexual Dysfunction Drugs Market Size, 2019-2031
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Sexual Dysfunction Drugs Revenue, 2019-2031
6.8.2 By Country - Middle East & Africa Sexual Dysfunction Drugs Sales, 2019-2031
6.8.3 Turkey Sexual Dysfunction Drugs Market Size, 2019-2031
6.8.4 Israel Sexual Dysfunction Drugs Market Size, 2019-2031
6.8.5 Saudi Arabia Sexual Dysfunction Drugs Market Size, 2019-2031
6.8.6 UAE Sexual Dysfunction Drugs Market Size, 2019-2031
7 Manufacturers & Brands Profiles
7.1 Pfizer
7.1.1 Pfizer Company Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Sexual Dysfunction Drugs Major Product Offerings
7.1.4 Pfizer Sexual Dysfunction Drugs Sales and Revenue in Global (2019-2024)
7.1.5 Pfizer Key News & Latest Developments
7.2 GlaxoSmithKline
7.2.1 GlaxoSmithKline Company Summary
7.2.2 GlaxoSmithKline Business Overview
7.2.3 GlaxoSmithKline Sexual Dysfunction Drugs Major Product Offerings
7.2.4 GlaxoSmithKline Sexual Dysfunction Drugs Sales and Revenue in Global (2019-2024)
7.2.5 GlaxoSmithKline Key News & Latest Developments
7.3 Merck
7.3.1 Merck Company Summary
7.3.2 Merck Business Overview
7.3.3 Merck Sexual Dysfunction Drugs Major Product Offerings
7.3.4 Merck Sexual Dysfunction Drugs Sales and Revenue in Global (2019-2024)
7.3.5 Merck Key News & Latest Developments
7.4 Eli Lilly
7.4.1 Eli Lilly Company Summary
7.4.2 Eli Lilly Business Overview
7.4.3 Eli Lilly Sexual Dysfunction Drugs Major Product Offerings
7.4.4 Eli Lilly Sexual Dysfunction Drugs Sales and Revenue in Global (2019-2024)
7.4.5 Eli Lilly Key News & Latest Developments
7.5 AbbVie
7.5.1 AbbVie Company Summary
7.5.2 AbbVie Business Overview
7.5.3 AbbVie Sexual Dysfunction Drugs Major Product Offerings
7.5.4 AbbVie Sexual Dysfunction Drugs Sales and Revenue in Global (2019-2024)
7.5.5 AbbVie Key News & Latest Developments
7.6 Bayer
7.6.1 Bayer Company Summary
7.6.2 Bayer Business Overview
7.6.3 Bayer Sexual Dysfunction Drugs Major Product Offerings
7.6.4 Bayer Sexual Dysfunction Drugs Sales and Revenue in Global (2019-2024)
7.6.5 Bayer Key News & Latest Developments
7.7 Teva Pharmaceutical Industries
7.7.1 Teva Pharmaceutical Industries Company Summary
7.7.2 Teva Pharmaceutical Industries Business Overview
7.7.3 Teva Pharmaceutical Industries Sexual Dysfunction Drugs Major Product Offerings
7.7.4 Teva Pharmaceutical Industries Sexual Dysfunction Drugs Sales and Revenue in Global (2019-2024)
7.7.5 Teva Pharmaceutical Industries Key News & Latest Developments
7.8 Takeda
7.8.1 Takeda Company Summary
7.8.2 Takeda Business Overview
7.8.3 Takeda Sexual Dysfunction Drugs Major Product Offerings
7.8.4 Takeda Sexual Dysfunction Drugs Sales and Revenue in Global (2019-2024)
7.8.5 Takeda Key News & Latest Developments
7.9 Apricus Biosciences
7.9.1 Apricus Biosciences Company Summary
7.9.2 Apricus Biosciences Business Overview
7.9.3 Apricus Biosciences Sexual Dysfunction Drugs Major Product Offerings
7.9.4 Apricus Biosciences Sexual Dysfunction Drugs Sales and Revenue in Global (2019-2024)
7.9.5 Apricus Biosciences Key News & Latest Developments
7.10 Emotional Brain
7.10.1 Emotional Brain Company Summary
7.10.2 Emotional Brain Business Overview
7.10.3 Emotional Brain Sexual Dysfunction Drugs Major Product Offerings
7.10.4 Emotional Brain Sexual Dysfunction Drugs Sales and Revenue in Global (2019-2024)
7.10.5 Emotional Brain Key News & Latest Developments
7.11 Ivix LLX
7.11.1 Ivix LLX Company Summary
7.11.2 Ivix LLX Sexual Dysfunction Drugs Business Overview
7.11.3 Ivix LLX Sexual Dysfunction Drugs Major Product Offerings
7.11.4 Ivix LLX Sexual Dysfunction Drugs Sales and Revenue in Global (2019-2024)
7.11.5 Ivix LLX Key News & Latest Developments
7.12 Leadiant Biosciences
7.12.1 Leadiant Biosciences Company Summary
7.12.2 Leadiant Biosciences Sexual Dysfunction Drugs Business Overview
7.12.3 Leadiant Biosciences Sexual Dysfunction Drugs Major Product Offerings
7.12.4 Leadiant Biosciences Sexual Dysfunction Drugs Sales and Revenue in Global (2019-2024)
7.12.5 Leadiant Biosciences Key News & Latest Developments
7.13 NexMed
7.13.1 NexMed Company Summary
7.13.2 NexMed Sexual Dysfunction Drugs Business Overview
7.13.3 NexMed Sexual Dysfunction Drugs Major Product Offerings
7.13.4 NexMed Sexual Dysfunction Drugs Sales and Revenue in Global (2019-2024)
7.13.5 NexMed Key News & Latest Developments
7.14 S1 Biopharma
7.14.1 S1 Biopharma Company Summary
7.14.2 S1 Biopharma Business Overview
7.14.3 S1 Biopharma Sexual Dysfunction Drugs Major Product Offerings
7.14.4 S1 Biopharma Sexual Dysfunction Drugs Sales and Revenue in Global (2019-2024)
7.14.5 S1 Biopharma Key News & Latest Developments
7.15 Vietstar Biomedical Research
7.15.1 Vietstar Biomedical Research Company Summary
7.15.2 Vietstar Biomedical Research Business Overview
7.15.3 Vietstar Biomedical Research Sexual Dysfunction Drugs Major Product Offerings
7.15.4 Vietstar Biomedical Research Sexual Dysfunction Drugs Sales and Revenue in Global (2019-2024)
7.15.5 Vietstar Biomedical Research Key News & Latest Developments
8 Global Sexual Dysfunction Drugs Production Capacity, Analysis
8.1 Global Sexual Dysfunction Drugs Production Capacity, 2019-2031
8.2 Sexual Dysfunction Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Sexual Dysfunction Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Sexual Dysfunction Drugs Supply Chain Analysis
10.1 Sexual Dysfunction Drugs Industry Value Chain
10.2 Sexual Dysfunction Drugs Upstream Market
10.3 Sexual Dysfunction Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Sexual Dysfunction Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Sexual Dysfunction Drugs in Global Market
Table 2. Top Sexual Dysfunction Drugs Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Sexual Dysfunction Drugs Revenue by Companies, (US$, Mn), 2019-2024
Table 4. Global Sexual Dysfunction Drugs Revenue Share by Companies, 2019-2024
Table 5. Global Sexual Dysfunction Drugs Sales by Companies, (K Pcs), 2019-2024
Table 6. Global Sexual Dysfunction Drugs Sales Share by Companies, 2019-2024
Table 7. Key Manufacturers Sexual Dysfunction Drugs Price (2019-2024) & (USD/Pcs)
Table 8. Global Manufacturers Sexual Dysfunction Drugs Product Type
Table 9. List of Global Tier 1 Sexual Dysfunction Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Sexual Dysfunction Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Sexual Dysfunction Drugs Revenue, (US$, Mn), 2022 & 2031
Table 12. By Type - Global Sexual Dysfunction Drugs Revenue (US$, Mn), 2019-2024
Table 13. By Type - Global Sexual Dysfunction Drugs Revenue (US$, Mn), 2024-2031
Table 14. By Type - Global Sexual Dysfunction Drugs Sales (K Pcs), 2019-2024
Table 15. By Type - Global Sexual Dysfunction Drugs Sales (K Pcs), 2024-2031
Table 16. By User ? Global Sexual Dysfunction Drugs Revenue, (US$, Mn), 2022 & 2031
Table 17. By User - Global Sexual Dysfunction Drugs Revenue (US$, Mn), 2019-2024
Table 18. By User - Global Sexual Dysfunction Drugs Revenue (US$, Mn), 2024-2031
Table 19. By User - Global Sexual Dysfunction Drugs Sales (K Pcs), 2019-2024
Table 20. By User - Global Sexual Dysfunction Drugs Sales (K Pcs), 2024-2031
Table 21. By Region ? Global Sexual Dysfunction Drugs Revenue, (US$, Mn), 2022 VS 2031
Table 22. By Region - Global Sexual Dysfunction Drugs Revenue (US$, Mn), 2019-2024
Table 23. By Region - Global Sexual Dysfunction Drugs Revenue (US$, Mn), 2024-2031
Table 24. By Region - Global Sexual Dysfunction Drugs Sales (K Pcs), 2019-2024
Table 25. By Region - Global Sexual Dysfunction Drugs Sales (K Pcs), 2024-2031
Table 26. By Country - North America Sexual Dysfunction Drugs Revenue, (US$, Mn), 2019-2024
Table 27. By Country - North America Sexual Dysfunction Drugs Revenue, (US$, Mn), 2024-2031
Table 28. By Country - North America Sexual Dysfunction Drugs Sales, (K Pcs), 2019-2024
Table 29. By Country - North America Sexual Dysfunction Drugs Sales, (K Pcs), 2024-2031
Table 30. By Country - Europe Sexual Dysfunction Drugs Revenue, (US$, Mn), 2019-2024
Table 31. By Country - Europe Sexual Dysfunction Drugs Revenue, (US$, Mn), 2024-2031
Table 32. By Country - Europe Sexual Dysfunction Drugs Sales, (K Pcs), 2019-2024
Table 33. By Country - Europe Sexual Dysfunction Drugs Sales, (K Pcs), 2024-2031
Table 34. By Region - Asia Sexual Dysfunction Drugs Revenue, (US$, Mn), 2019-2024
Table 35. By Region - Asia Sexual Dysfunction Drugs Revenue, (US$, Mn), 2024-2031
Table 36. By Region - Asia Sexual Dysfunction Drugs Sales, (K Pcs), 2019-2024
Table 37. By Region - Asia Sexual Dysfunction Drugs Sales, (K Pcs), 2024-2031
Table 38. By Country - South America Sexual Dysfunction Drugs Revenue, (US$, Mn), 2019-2024
Table 39. By Country - South America Sexual Dysfunction Drugs Revenue, (US$, Mn), 2024-2031
Table 40. By Country - South America Sexual Dysfunction Drugs Sales, (K Pcs), 2019-2024
Table 41. By Country - South America Sexual Dysfunction Drugs Sales, (K Pcs), 2024-2031
Table 42. By Country - Middle East & Africa Sexual Dysfunction Drugs Revenue, (US$, Mn), 2019-2024
Table 43. By Country - Middle East & Africa Sexual Dysfunction Drugs Revenue, (US$, Mn), 2024-2031
Table 44. By Country - Middle East & Africa Sexual Dysfunction Drugs Sales, (K Pcs), 2019-2024
Table 45. By Country - Middle East & Africa Sexual Dysfunction Drugs Sales, (K Pcs), 2024-2031
Table 46. Pfizer Company Summary
Table 47. Pfizer Sexual Dysfunction Drugs Product Offerings
Table 48. Pfizer Sexual Dysfunction Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2019-2024)
Table 49. Pfizer Key News & Latest Developments
Table 50. GlaxoSmithKline Company Summary
Table 51. GlaxoSmithKline Sexual Dysfunction Drugs Product Offerings
Table 52. GlaxoSmithKline Sexual Dysfunction Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2019-2024)
Table 53. GlaxoSmithKline Key News & Latest Developments
Table 54. Merck Company Summary
Table 55. Merck Sexual Dysfunction Drugs Product Offerings
Table 56. Merck Sexual Dysfunction Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2019-2024)
Table 57. Merck Key News & Latest Developments
Table 58. Eli Lilly Company Summary
Table 59. Eli Lilly Sexual Dysfunction Drugs Product Offerings
Table 60. Eli Lilly Sexual Dysfunction Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2019-2024)
Table 61. Eli Lilly Key News & Latest Developments
Table 62. AbbVie Company Summary
Table 63. AbbVie Sexual Dysfunction Drugs Product Offerings
Table 64. AbbVie Sexual Dysfunction Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2019-2024)
Table 65. AbbVie Key News & Latest Developments
Table 66. Bayer Company Summary
Table 67. Bayer Sexual Dysfunction Drugs Product Offerings
Table 68. Bayer Sexual Dysfunction Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2019-2024)
Table 69. Bayer Key News & Latest Developments
Table 70. Teva Pharmaceutical Industries Company Summary
Table 71. Teva Pharmaceutical Industries Sexual Dysfunction Drugs Product Offerings
Table 72. Teva Pharmaceutical Industries Sexual Dysfunction Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2019-2024)
Table 73. Teva Pharmaceutical Industries Key News & Latest Developments
Table 74. Takeda Company Summary
Table 75. Takeda Sexual Dysfunction Drugs Product Offerings
Table 76. Takeda Sexual Dysfunction Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2019-2024)
Table 77. Takeda Key News & Latest Developments
Table 78. Apricus Biosciences Company Summary
Table 79. Apricus Biosciences Sexual Dysfunction Drugs Product Offerings
Table 80. Apricus Biosciences Sexual Dysfunction Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2019-2024)
Table 81. Apricus Biosciences Key News & Latest Developments
Table 82. Emotional Brain Company Summary
Table 83. Emotional Brain Sexual Dysfunction Drugs Product Offerings
Table 84. Emotional Brain Sexual Dysfunction Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2019-2024)
Table 85. Emotional Brain Key News & Latest Developments
Table 86. Ivix LLX Company Summary
Table 87. Ivix LLX Sexual Dysfunction Drugs Product Offerings
Table 88. Ivix LLX Sexual Dysfunction Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2019-2024)
Table 89. Ivix LLX Key News & Latest Developments
Table 90. Leadiant Biosciences Company Summary
Table 91. Leadiant Biosciences Sexual Dysfunction Drugs Product Offerings
Table 92. Leadiant Biosciences Sexual Dysfunction Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2019-2024)
Table 93. Leadiant Biosciences Key News & Latest Developments
Table 94. NexMed Company Summary
Table 95. NexMed Sexual Dysfunction Drugs Product Offerings
Table 96. NexMed Sexual Dysfunction Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2019-2024)
Table 97. NexMed Key News & Latest Developments
Table 98. S1 Biopharma Company Summary
Table 99. S1 Biopharma Sexual Dysfunction Drugs Product Offerings
Table 100. S1 Biopharma Sexual Dysfunction Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2019-2024)
Table 101. S1 Biopharma Key News & Latest Developments
Table 102. Vietstar Biomedical Research Company Summary
Table 103. Vietstar Biomedical Research Sexual Dysfunction Drugs Product Offerings
Table 104. Vietstar Biomedical Research Sexual Dysfunction Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2019-2024)
Table 105. Vietstar Biomedical Research Key News & Latest Developments
Table 106. Sexual Dysfunction Drugs Production Capacity (K Pcs) of Key Manufacturers in Global Market, 2021-2024 (K Pcs)
Table 107. Global Sexual Dysfunction Drugs Capacity Market Share of Key Manufacturers, 2021-2024
Table 108. Global Sexual Dysfunction Drugs Production by Region, 2019-2024 (K Pcs)
Table 109. Global Sexual Dysfunction Drugs Production by Region, 2024-2031 (K Pcs)
Table 110. Sexual Dysfunction Drugs Market Opportunities & Trends in Global Market
Table 111. Sexual Dysfunction Drugs Market Drivers in Global Market
Table 112. Sexual Dysfunction Drugs Market Restraints in Global Market
Table 113. Sexual Dysfunction Drugs Raw Materials
Table 114. Sexual Dysfunction Drugs Raw Materials Suppliers in Global Market
Table 115. Typical Sexual Dysfunction Drugs Downstream
Table 116. Sexual Dysfunction Drugs Downstream Clients in Global Market
Table 117. Sexual Dysfunction Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Sexual Dysfunction Drugs Segment by Type in 2022
Figure 2. Sexual Dysfunction Drugs Segment by User in 2022
Figure 3. Global Sexual Dysfunction Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Sexual Dysfunction Drugs Market Size: 2022 VS 2031 (US$, Mn)
Figure 6. Global Sexual Dysfunction Drugs Revenue, 2019-2031 (US$, Mn)
Figure 7. Sexual Dysfunction Drugs Sales in Global Market: 2019-2031 (K Pcs)
Figure 8. The Top 3 and 5 Players Market Share by Sexual Dysfunction Drugs Revenue in 2022
Figure 9. By Type - Global Sexual Dysfunction Drugs Revenue, (US$, Mn), 2022 & 2031
Figure 10. By Type - Global Sexual Dysfunction Drugs Revenue Market Share, 2019-2031
Figure 11. By Type - Global Sexual Dysfunction Drugs Sales Market Share, 2019-2031
Figure 12. By Type - Global Sexual Dysfunction Drugs Price (USD/Pcs), 2019-2031
Figure 13. By User - Global Sexual Dysfunction Drugs Revenue, (US$, Mn), 2022 & 2031
Figure 14. By User - Global Sexual Dysfunction Drugs Revenue Market Share, 2019-2031
Figure 15. By User - Global Sexual Dysfunction Drugs Sales Market Share, 2019-2031
Figure 16. By User - Global Sexual Dysfunction Drugs Price (USD/Pcs), 2019-2031
Figure 17. By Region - Global Sexual Dysfunction Drugs Revenue, (US$, Mn), 2022 & 2031
Figure 18. By Region - Global Sexual Dysfunction Drugs Revenue Market Share, 2019 VS 2022 VS 2031
Figure 19. By Region - Global Sexual Dysfunction Drugs Revenue Market Share, 2019-2031
Figure 20. By Region - Global Sexual Dysfunction Drugs Sales Market Share, 2019-2031
Figure 21. By Country - North America Sexual Dysfunction Drugs Revenue Market Share, 2019-2031
Figure 22. By Country - North America Sexual Dysfunction Drugs Sales Market Share, 2019-2031
Figure 23. US Sexual Dysfunction Drugs Revenue, (US$, Mn), 2019-2031
Figure 24. Canada Sexual Dysfunction Drugs Revenue, (US$, Mn), 2019-2031
Figure 25. Mexico Sexual Dysfunction Drugs Revenue, (US$, Mn), 2019-2031
Figure 26. By Country - Europe Sexual Dysfunction Drugs Revenue Market Share, 2019-2031
Figure 27. By Country - Europe Sexual Dysfunction Drugs Sales Market Share, 2019-2031
Figure 28. Germany Sexual Dysfunction Drugs Revenue, (US$, Mn), 2019-2031
Figure 29. France Sexual Dysfunction Drugs Revenue, (US$, Mn), 2019-2031
Figure 30. U.K. Sexual Dysfunction Drugs Revenue, (US$, Mn), 2019-2031
Figure 31. Italy Sexual Dysfunction Drugs Revenue, (US$, Mn), 2019-2031
Figure 32. Russia Sexual Dysfunction Drugs Revenue, (US$, Mn), 2019-2031
Figure 33. Nordic Countries Sexual Dysfunction Drugs Revenue, (US$, Mn), 2019-2031
Figure 34. Benelux Sexual Dysfunction Drugs Revenue, (US$, Mn), 2019-2031
Figure 35. By Region - Asia Sexual Dysfunction Drugs Revenue Market Share, 2019-2031
Figure 36. By Region - Asia Sexual Dysfunction Drugs Sales Market Share, 2019-2031
Figure 37. China Sexual Dysfunction Drugs Revenue, (US$, Mn), 2019-2031
Figure 38. Japan Sexual Dysfunction Drugs Revenue, (US$, Mn), 2019-2031
Figure 39. South Korea Sexual Dysfunction Drugs Revenue, (US$, Mn), 2019-2031
Figure 40. Southeast Asia Sexual Dysfunction Drugs Revenue, (US$, Mn), 2019-2031
Figure 41. India Sexual Dysfunction Drugs Revenue, (US$, Mn), 2019-2031
Figure 42. By Country - South America Sexual Dysfunction Drugs Revenue Market Share, 2019-2031
Figure 43. By Country - South America Sexual Dysfunction Drugs Sales Market Share, 2019-2031
Figure 44. Brazil Sexual Dysfunction Drugs Revenue, (US$, Mn), 2019-2031
Figure 45. Argentina Sexual Dysfunction Drugs Revenue, (US$, Mn), 2019-2031
Figure 46. By Country - Middle East & Africa Sexual Dysfunction Drugs Revenue Market Share, 2019-2031
Figure 47. By Country - Middle East & Africa Sexual Dysfunction Drugs Sales Market Share, 2019-2031
Figure 48. Turkey Sexual Dysfunction Drugs Revenue, (US$, Mn), 2019-2031
Figure 49. Israel Sexual Dysfunction Drugs Revenue, (US$, Mn), 2019-2031
Figure 50. Saudi Arabia Sexual Dysfunction Drugs Revenue, (US$, Mn), 2019-2031
Figure 51. UAE Sexual Dysfunction Drugs Revenue, (US$, Mn), 2019-2031
Figure 52. Global Sexual Dysfunction Drugs Production Capacity (K Pcs), 2019-2031
Figure 53. The Percentage of Production Sexual Dysfunction Drugs by Region, 2022 VS 2031
Figure 54. Sexual Dysfunction Drugs Industry Value Chain
Figure 55. Marketing Channels
